ReviewCureus2025

Comparative Cardiovascular Outcomes of Dapagliflozin Versus Empagliflozin in Patients With Type 2 Diabetes: A Meta-Analysis.

Rhuna Dhana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.